PSYCHOLOGICAL MEDICINE, vol.47, no.6, pp.1030-1040, 2017 (SCI-Expanded)
Background. Individuals with schizophrenia are at greater risk for metabolic syndrome (MetS) which is associated with cognitive deficits in the general population. MetS might be potentially an important contributing factor to cognitive impairment in schizophrenia.